Los Angeles Capital Management
AVNS

Los Angeles Capital Management’s Avanos Medical AVNS Stock Holding History

Los Angeles Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-297
Closed -$3.31K – 2406
2025
Q4 		$3.31K Buy
+297
New +$3.4K ﹤0.01% 2364
2019
Q2 		– Sell
-16,065
Closed -$686K – 1344
2019
Q1 		$686K Sell
16,065
-4,480
-22% -$201K ﹤0.01% 987
2018
Q4 		$920K Sell
20,545
-2,845
-12% -$149K 0.01% 769
2018
Q3 		$1.6M Buy
23,390
+6,430
+38% +$414K 0.01% 728
2018
Q2 		$971K Buy
16,960
+11,650
+219% +$616K 0.01% 911
2018
Q1 		$245K Buy
5,310
+745
+16% +$35.4K ﹤0.01% 1218
2017
Q4 		$211K Sell
4,565
-17,972
-80% -$826K ﹤0.01% 1256
2017
Q3 		$1.01M Hold
22,537
– – 0.01% 813
2017
Q2 		$885K Buy
+22,537
New +$852K 0.01% 789
2015
Q2 		– Sell
-4,702
Closed -$231K – 1203
2015
Q1 		$231K Sell
4,702
-8,897
-65% -$412K ﹤0.01% 1129
2014
Q4 		$618K Buy
+13,599
New +$534K 0.01% 777

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Los Angeles Capital Management's AVNS Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 297 shares — an estimated $3.31K sold.

Los Angeles Capital Management first reported a position in AVNS in Q4 2014 and held it in 11 quarters. The position peaked at $1.6M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 297 Avanos Medical shares in Q1 2026, an estimated $3.31K.
  • Los Angeles Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 11 quarters.
  • Los Angeles Capital Management's Avanos Medical position peaked at $1.6M in Q3 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.